Please login to the form below

Not currently logged in
Email:
Password:

Merck KGaA appoints chief strategy officer

Isabel De Paoli will take up the role from 1 October

Merck KGaA Isabel De PaoliDarmstadt, Germany-based Merck KGaA has appointed Isabel De Paoli to the newly-created role of chief strategy officer.

De Paoli will head up the pharma firm's group strategy and transformation function, with responsibility for the integration of existing strategies, innovation and digitalization across Merck.

She takes up the chief strategy officer post in addition to her current position as head of group communications, reporting to Merck's chief executive and chairman Stefan Oschmann.

De Paoli first joined Merck in 2006 as business development manager, chemicals before promotion to head of strategic planning oncology in 2009. She has been responsible for the group's strategy and development process since 2012, taking on her current role last year.

Prior to this, De Paoli worked as a consultant for The Boston Consulting Group, also bringing experience from private equity firm Permira.

Oschmann said: “Over the past year, we've started to explore a variety of very promising innovation and digitalization projects to deliver on our promise as a science and technology company.

“Going forward, we will integrate those initiatives in a coherent strategy to ensure swift and successful implementation.

“Isabel De Paoli has built a strong track record in defining strategies and setting up organisations that yield efficient and effective returns - most recently in her role as head of group communications, successfully streamlining the organisation to support strategic objectives of our healthcare, life science and performance materials businesses.”

29th September 2016

From: Sales

Share

Tags

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

Tree
Pharma’s vital role in sustainability and corporate social responsibility
Pharma is in the spotlight as tough questions about sustainability commitments continue to arise...
Infographic: Therapy Watch Hyperlipidaemia
Our latest infographic offers an introduction to the real-world insights collected by our Hyperlipidaemia study....
Article: The rise of the healthcare influencer
In our latest article for Pharmaphorum Deep Dive, we explore the opportunities and benefits for healthcare companies in the online influencer space....